ProBiotix Health (LON: PBX) increased interim revenues by 84% to £1.01m and the loss has been halved to £262,000. The probiotics-based healthcare company is expanding sales in North America and Europe. A North American contract manufacturing deal is being discussed. Operational separation from OptiBiotix should be completed by the end of the year. There was £865,000 in the bank at the end of June 2024. The share price increased 12.5% to 4.5p.
Skincare treatments developer Incanthera (LON: INC) reported figures for the year to March 2024 showing a steady loss of £1.47m. There was a cash outflow from operating activities of £838,000 and £61,000 in cash at the end of March 2024. There were no revenues during this period. The deal with Cosmetics chain Marionnaud should be generating sales in the near future. The share price improved 1.7% to 29.5p. That is 354% higher than at the beginning of 2024.
FALLERS
St Mark Homes (LON: SMAP) shares fell by a further two-thirds to 2p ahead of the departure from Aquis on 2 September.
Exchange services provider Aquis Exchange (LON: AQX), which is also quoted on the Aquis Stock Exchange, has been hit by one technology contract not being renewed, because of the client’s trading problems. That will knock £1m off revenues and pre-tax profit in 2024. The other parts of the group all grew revenues in the first half with Aquis Stick Exchange trading volumes 44% ahead. Canaccord Genuity has cut its 2024 pre-tax profit forecast from £6.3m to £4.9m with the rest of the shortfall due to increased investment. The interims will be published on 12 September. The share price slumped 18.2% to 390p.
CBD-based treatments developer Ananda Developments (LON: ANA) made a £383,000 loss in the quarter to July 2024. Net assets were £723,000. The share price dipped 11.1% to 0.4p.
KR1 (LON: KR1) had net assets of 71.92p/share at the end of July 2024. The income from digital assets during the month was £805,000. The share price declined 8.82% to 1.55p.
Equipmake (LON: EQIP) has received an initial order for five zero emission drivetrains from South American bus manufacturer Agrale. This follows the recent trial. The share price slipped 7.69% to 3p.
James and Alexandra Pace has a 4.1% stake in Shepherd Neame (LON: SHEP). The share price dipped 5.6% to 632.5p.